Abstract:Rationale
Long‐life ventilatory assistance is necessary for survival in pediatric patients with congenital central hypoventilation syndrome (CCHS). Invasive mechanical ventilation (IMV) through tracheostomy is the most used method, especially in the first years of life when the central nervous system is maturing. Nevertheless, IMV via tracheostomy is not ideal because tracheostomy in children is associated with impaired speech and language development, also frequent infections of the lower airway tract occur.
… Show more
“…Transition from tracheostomy to mask ventilation may be considered at varying ages, mainly for those with adequate ventilation during wakefulness [66]. Some authors consider the optimal time for transition as being older children (e.g.…”
Background
Congenital Central Hypoventilation Syndrome (CCHS) is a rare condition characterized by an alveolar hypoventilation due to a deficient autonomic central control of ventilation and a global autonomic dysfunction. Paired-like homeobox 2B (PHOX2B) mutations are found in most of the patients with CCHS. In recent years, the condition has evolved from a life-threatening neonatal onset disorder to include broader and milder clinical presentations, affecting children, adults and families. Genes other than PHOX2B have been found responsible for CCHS in rare cases and there are as yet other unknown genes that may account for the disease. At present, management relies on lifelong ventilatory support and close follow up of dysautonomic progression.
Body
This paper provides a state-of-the-art comprehensive description of CCHS and of the components of diagnostic evaluation and multi-disciplinary management, as well as considerations for future research.
Conclusion
Awareness and knowledge of the diagnosis and management of this rare disease should be brought to a large health community including adult physicians and health carers.
“…Transition from tracheostomy to mask ventilation may be considered at varying ages, mainly for those with adequate ventilation during wakefulness [66]. Some authors consider the optimal time for transition as being older children (e.g.…”
Background
Congenital Central Hypoventilation Syndrome (CCHS) is a rare condition characterized by an alveolar hypoventilation due to a deficient autonomic central control of ventilation and a global autonomic dysfunction. Paired-like homeobox 2B (PHOX2B) mutations are found in most of the patients with CCHS. In recent years, the condition has evolved from a life-threatening neonatal onset disorder to include broader and milder clinical presentations, affecting children, adults and families. Genes other than PHOX2B have been found responsible for CCHS in rare cases and there are as yet other unknown genes that may account for the disease. At present, management relies on lifelong ventilatory support and close follow up of dysautonomic progression.
Body
This paper provides a state-of-the-art comprehensive description of CCHS and of the components of diagnostic evaluation and multi-disciplinary management, as well as considerations for future research.
Conclusion
Awareness and knowledge of the diagnosis and management of this rare disease should be brought to a large health community including adult physicians and health carers.
“…La ventilación por traqueostomía es el modo más eficáz en los primeros años de vida, garantiza una adecuada ventilación y oxigenación (3,9) hasta que los niños alcancen una adecuada maduración del SNC y aparato respiratorio (16,23,41); la Sociedad Americana de Tórax (American Thoracic Society-ATS) recomienda la ventilación por traqueostomía durante los primeros 6 a 8 años de vida en CCHS, para optimizar un desarrollo neurocognitivo adecuado (16,17,19). La traqueostomía debe ser realizada antes del mes de vida, las cánulas usadas no tienen balón y son de menor tamaño, para permitir una fuga lo suficientemente adecuada como para usar válvulas de habla unidireccional (17,19,23).…”
Section: Abordaje Terapeuticounclassified
“…Al respecto hay poco descrito en niños con ROHHAD, casos aislados reportan con éxito el tratamiento de la hipoventilación alveolar utilizando AVAPS (42). La transición de ventilación invasiva por traqueostomía a VNI, ocurre principalmente en pacientes con fenotipos leves de CCHS que ventilan adecuadamente durante la vigilia (17,18,43); sin embargo hasta la fecha no existen indicaciones concretas sobre el momento óptimo para la transición, porque es una opción que está muy vinculada a las características propias de cada paciente y su entorno familiar; pero culminar un programa de decanulación antes de la adolescencia puede ser una buena opción (41,44). Aunque se han reportado casos aislados de éxito donde se logra la transición a edades más tempranas (3 años), enfatizando que todo caso debe ser analizado de manera personalizada (18).…”
El síndrome de hipoventilación central congénita (CCHS) y síndrome de obesidad de inicio rápido con disfunción hipotalámica, hipoventilación y desregulación autonómica (ROHHAD), son causas poco comunes de hipoventilación durante el sueño en la población pediátrica. Este grupo de trastornos se caracterizan por ausencia o disminución en el control automático de la ventilación, sensibilidad disminuida de los quimioreceptores al CO2, provocando hipoventilación durante el sueño e incluso en vigilia, en los casos más severos. Por estas razones es importante diagnosticarlos y tratarlos oportunamente. El objetivo de esta revisión es proporcionar literatura actual y completa, para poder identificar, tratar y referir a éste grupo de niños tempranamente, y así disminuir las complicaciones y/o comorbilidades asociadas a corto y largo plazo, mejorando su calidad de vida
“…An increasing number of children with CCHS have been successfully transitioned from invasive ventilation to BiPAP ventilation and recently a proposal of an algorithm for decannulation was published (35). By the moment there are not specific indications about optimal time to switch from tracheostomy to NPPV because it is a choice closely linked to the patient and his family, but ending the decannulation program before adolescence can be a good option.…”
Central hypoventilation (CH) is a quite rare disorder caused by some congenital or acquired conditions. It is featured by increased arterial concentration of serum carbon dioxide related to an impairment of respiratory drive. Patients affected by CH need to be treated by mechanical ventilation in order to achieve appropriate ventilation and oxygenation both in sleep and wakefulness. In fact, in severe form of Congenital Central Hypoventilation Syndrome (CCHS) hypercarbia can be present even during the day. Positive pressure ventilation via tracheostomy is the first therapeutic option in this clinical condition, especially in congenital forms. Non-Invasive ventilation is a an option that must be reserved for more stable clinical situations and that requires careful monitoring over time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.